"Phosphocreatine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996)
| Descriptor ID |
D010725
|
| MeSH Number(s) |
D12.125.373.603 D12.125.740.675
|
| Concept/Terms |
Phosphocreatine- Phosphocreatine
- Phosphorylcreatine
- Creatine Phosphate
- Phosphate, Creatine
|
Below are MeSH descriptors whose meaning is more general than "Phosphocreatine".
Below are MeSH descriptors whose meaning is more specific than "Phosphocreatine".
This graph shows the total number of publications written about "Phosphocreatine" by people in this website by year, and whether "Phosphocreatine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 3 | 3 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphocreatine" by people in Profiles.
-
Mapping Age Differences in Brain Energy Metabolites and Metabolic Markers of Cellular Membrane Production and Degradation With 31P Magnetic Resonance Spectroscopy. Hum Brain Mapp. 2024 Oct; 45(14):e70039.
-
Altered metabolomic-genomic signature: A potential noninvasive biomarker of epilepsy. Epilepsia. 2017 09; 58(9):1626-1636.
-
Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model. Neuropharmacology. 2015 Dec; 99:318-27.
-
Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy study. Psychiatry Res. 2010 Nov 30; 184(2):71-6.
-
Lower N-acetyl-aspartate levels in prefrontal cortices in pediatric bipolar disorder: a ?H magnetic resonance spectroscopy study. J Am Acad Child Adolesc Psychiatry. 2011 Jan; 50(1):85-94.
-
Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel (1)H spectroscopy study. Psychiatry Res. 2009 Dec 30; 174(3):177-83.
-
Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study. J Psychiatr Res. 2010 Apr; 44(5):278-85.
-
Molecular neurodevelopment: an in vivo 31P-1H MRSI study. J Int Neuropsychol Soc. 2009 Sep; 15(5):671-83.
-
An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res. 2008 Jul 15; 163(2):97-105.
-
Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder. Neuroreport. 2007 Oct 08; 18(15):1567-70.